Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE)
Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE)
批准号:
nhmrc : GNT1099452
负责人:
A/Pr Jan De Waele
金额:
$215.83万
依托单位国家:
澳大利亚
项目类别:
Centres of Research Excellence
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 --
中文摘要
抗菌剂的无效剂量导致了抗菌素耐药性的升级,这种耐药性现在遍及医疗保健系统。重症监护病房和移植后的患者通常患有感染,更有可能治疗失败,出现耐药微生物。在这些研究中,我们将描述这些难以治疗的患者应该使用的抗菌药的剂量,并迅速分享这些药物用于常规临床。
英文摘要
Ineffective dosing of antimicrobials has contributed to the escalation of antimicrobial resistance which now pervades the healthcare system. Patients in the intensive care unit and post-transplant are examples of patients who commonly have infections, are more likely to fail treatment and have resistant microbes emerge. In these studies we will characterise the doses of antimicrobials that should be used in these difficult-to-treat patients and rapidly share these for routine clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLING III: A phase III randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients
-
批准号:nhmrc : GNT1121481
-
项目类别:Project Grants
-
资助金额:$326.99万
-
财政年份:2017
-
负责人:A/Pr Jan De Waele
-
依托单位:
海外基金